A case of lactic acidosis developing during antiretroviral therapy in a patient with HIV infection

D S Konnov , O G Yurin

Epidemiology and Infectious Diseases ›› 2010, Vol. 15 ›› Issue (3) : 54 -56.

PDF
Epidemiology and Infectious Diseases ›› 2010, Vol. 15 ›› Issue (3) : 54 -56. DOI: 10.17816/EID40500
Articles
other

A case of lactic acidosis developing during antiretroviral therapy in a patient with HIV infection

Author information +
History +
PDF

Abstract

The paper describes a clinical case of development of lactic acidosis, a specific delayed complication, in a HIV-infected patient who received antiretroviral therapy (ART) for 1.5 years and was adherent to ART. During the latter, the patient achieved stable clinical, immunological, and virologic effects. However, 1.5 years later, the patient was found to have blood biochemical changes as blood accumulation and elevated levels of lactate; clinical signs of lactic acidosis appeared. His therapy regimen with zidovudine and didanosine was changed to abacavir and lamivudine and pathogenetic therapy was performed, which relieved lactic acidosis.Long-term adverse reactions of the used drugs, which endanger the long-range goals of ART (the quality of life and its duration in patients), play an important role in patients adherent to ART despite the clinical, immunological, and virologic successes of treatment.

Keywords

HIV infection / antiretroviral therapy / lactic acidosis

Cite this article

Download citation ▾
D S Konnov, O G Yurin. A case of lactic acidosis developing during antiretroviral therapy in a patient with HIV infection. Epidemiology and Infectious Diseases, 2010, 15(3): 54-56 DOI:10.17816/EID40500

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ВИЧ-инфекция и СПИД: Клинические рекомендации. - М., 2009

[2]

Клинические аспекты ВИЧ-инфекции / Под ред. Д. Бартлет, Дж. Галлант. - М., 2007. - С. 120-122.

[3]

Лечение и помощь при ВИЧ/СПИДе: клинические протоколы для Европейского региона ВОЗ. 2009 (http://www.euro.who.int/document/e90840R.pdf).

[4]

Brinkman K., Smeitink J. A., Romijn J. A., Reiss P. // Lancet. - 1999. - Vol. 354. - P. 1112.

[5]

Côté H. C., Brumme Z. L., Craib K. J. // N. Engl. J. Med. - 2002. - Vol. 346. - P. 811.

[6]

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. - 2009. (http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf).

[7]

Falcö V., Rodriguez D., Ribera E. et al. // Clin. Infect. Dis. - 2002. - Vol. 34. - P. 838.

[8]

John M., Moore C. B., James I. R. // AIDS. - 2001. - Vol. 15. - P. 717.

[9]

Miller K. D., Cameron M., Wood L. V. // Ann. Intern. Med. - 2000. - Vol. 133. - P. 192.

[10]

Tsiodras S., Mantzoros C., Hammer S., Samore M. // Arch. Intern. Med. - 2000. - Vol. 160. - P. 2050.

RIGHTS & PERMISSIONS

Eco-vector

AI Summary AI Mindmap
PDF

146

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/